Suchergebnisse - "Swaminathan, Srividya"

PubPharm (5)

1

MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Smith, B. | Deutzmann, A. | Correa, K. | +13

2

A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation

enthalten in: Scientific reports | 2021

von Hori, S. | Tong, L. | Swaminathan, S. | +4

3

MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies

enthalten in: Nature communications | 2020

von Swaminathan, S. | Hansen, A. | Heftdal, L. | +9

4

BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint

enthalten in: Nature medicine | 2013

von Swaminathan, S. | Huang, C. | Geng, H. | +18

CommentIn: Cancer Cell. 2013 Sep 9;24(3):282-4. - PMID 24029225

5

BCL6 is critical for the development of a diverse primary B cell repertoire

enthalten in: The Journal of experimental medicine | 2010

von Duy, C. | Yu, J. | Nahar, R. | +18

1
[1]